Financial reports
10-Q
2016 Q3
Quarterly report
3 Nov 16
10-Q
2016 Q2
Quarterly report
11 Aug 16
10-Q
2016 Q1
Quarterly report
4 May 16
10-K
2015 FY
Annual report
16 Mar 16
10-Q
2015 Q3
Quarterly report
4 Nov 15
10-Q
2015 Q2
Quarterly report
5 Aug 15
10-Q
2015 Q1
Quarterly report
14 May 15
10-K
2014 FY
Annual report
26 Feb 15
10-Q
2014 Q3
Quarterly report
5 Nov 14
10-Q
2014 Q2
Quarterly report
5 Aug 14
Current reports
8-K
Unregistered Sales of Equity Securities
22 Nov 16
8-K
Entry into a Material Definitive Agreement
14 Nov 16
8-K
Entry into a Material Definitive Agreement
3 Nov 16
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
19 Oct 16
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
6 Sep 16
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
1 Sep 16
8-K
Departure of Directors or Certain Officers
22 Jul 16
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
20 Jul 16
8-K
Submission of Matters to a Vote of Security Holders
15 Jun 16
8-K
Departure of Directors or Certain Officers
7 Apr 16
Registration and prospectus
15-12B
Securities registration termination
2 Dec 16
25
Voluntary exchange delisting
14 Nov 16
POS AM
Prospectus update (post-effective amendment)
3 Nov 16
S-8 POS
Registration of securities for employees (post-effective amendment)
3 Nov 16
424B5
Prospectus supplement for primary offering
25 Aug 15
424B5
Prospectus supplement for primary offering
1 May 15
424B5
Prospectus supplement for primary offering
30 Apr 15
424B5
Prospectus supplement for primary offering
13 Mar 15
S-3
Shelf registration
2 Jan 15
S-8
Registration of securities for employees
16 Dec 13
Proxies
DEF 14A
Definitive proxy
1 Dec 16
PREM14A
Preliminary proxy related to merger
22 Nov 16
DEFA14A
Additional proxy soliciting materials
3 Nov 16
DEF 14A
Definitive proxy
28 Apr 16
DEFA14A
Additional proxy soliciting materials
28 Apr 16
DEF 14A
Definitive proxy
9 Apr 15
PRE 14A
Preliminary proxy
30 Mar 15
DEF 14A
Definitive proxy
2 Apr 14
Other
EFFECT
Notice of effectiveness
7 Nov 16
EFFECT
Notice of effectiveness
15 Jan 15
CT ORDER
Confidential treatment order
18 Nov 14
CORRESP
Correspondence with SEC
11 Dec 13
EFFECT
Notice of effectiveness
11 Dec 13
CORRESP
Correspondence with SEC
10 Dec 13
CORRESP
Correspondence with SEC
19 Nov 13
CORRESP
Correspondence with SEC
18 Nov 13
CORRESP
Correspondence with SEC
18 Nov 13
CORRESP
Correspondence with SEC
8 Nov 13
Ownership
SC 13G/A
Robins David C.
16 Feb 21
SC 13G/A
TETRALOGIC PHARMACEUTICALS Corp
15 Feb 19
3
David C. Robins
27 Jun 18
SC 13G/A
TETRALOGIC PHARMACEUTICALS Corp
19 Sep 17
SC 13G/A
TETRALOGIC PHARMACEUTICALS Corp
18 Sep 17
SC 13G/A
TETRALOGIC PHARMACEUTICALS Corp
30 Aug 17
SC 13G/A
TETRALOGIC PHARMACEUTICALS Corp
17 Aug 17
SC 13G
TETRALOGIC PHARMACEUTICALS Corp
4 Aug 17
4
Change in insider ownership
16 Nov 16
3
Initial statement of insider ownership
14 Nov 16